Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy
2016; Lippincott Williams & Wilkins; Volume: 135; Issue: 2 Linguagem: Inglês
10.1161/circulationaha.116.026056
ISSN1524-4539
AutoresHarsh Golwala, Navkaranbir S. Bajaj, Garima Arora, Pankaj Arora,
Tópico(s)Cardiomyopathy and Myosin Studies
ResumoHomeCirculationVol. 135, No. 2Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBImplantable Cardioverter-Defibrillator for Nonischemic CardiomyopathyAn Updated Meta-Analysis Harsh Golwala, MD, Navkaranbir Singh Bajaj, MD, MPH, Garima Arora, MD and Pankaj Arora, MD Harsh GolwalaHarsh Golwala From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (G.A., P.A.). , Navkaranbir Singh BajajNavkaranbir Singh Bajaj From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (G.A., P.A.). , Garima AroraGarima Arora From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (G.A., P.A.). and Pankaj AroraPankaj Arora From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (G.A., P.A.). Originally published19 Dec 2016https://doi.org/10.1161/CIRCULATIONAHA.116.026056Circulation. 2017;135:201–203Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 10, 2017: Previous Version 1 The use of implantable cardioverter-defibrillators (ICDs) has been a major advancement in patients with ischemic cardiomyopathy with reduced ejection fraction 1100 patients with NICM on optimal medical therapy (OMT) and cardiac resynchronization therapy (CRT) to ICD versus no ICD for primary prevention of sudden cardiac death, revealed no difference in all-cause mortality between the 2 groups at 5-year follow-up.4 Although the primary results of DANISH were neutral, the ICD group showed reduction in incidence of sudden cardiac death by half, and there was an interaction of survival benefit with ICD use in younger patients with NICM. In light of the recent data, we sought to update the meta-analysis of RCTs assessing the utility of ICD for primary prevention in patients with NICM.We searched the MEDLINE, PUBMED, and SCOPUS databases using the following keywords: implantable cardioverter defibrillator, ICD, cardiac resynchronization therapy, CRT, heart failure, cardiomyopathy, and randomized controlled trials from their inception to October 20, 2016. After examining 773 relevant studies, we included 6 RCTs that assessed the efficacy of ICD for primary prevention in patients with NICM. Two authors (H.G., N.B.) independently extracted data from each individual study. We calculated risk ratios/hazard ratios and 95% confidence intervals (CIs) using the available event rate data from individual trials when these measures were not reported in the individual trial. The risk measures and 95% CIs were log transformed and combined using random-effects models. Data were analyzed for heterogeneity using the I2 statistic. We also performed a separate analysis of trials with/without CRT use to assess the differential effect of CRT on the efficacy of ICDs. Analyses were performed using Stata V14.1 statistical software.We identified 6 RCTs enrolling 2970 patients with NICM to study the efficacy of ICDs for primary prevention. Pooled analysis of the 6 RCTs (including those with CRT defibrillator) demonstrated a statistically significant 23% risk reduction in all-cause mortality in favor of ICD therapy (hazard ratio, 0.77; 95% CI, 0.64–0.91) (Figure). In addition, when we performed separate analysis of trials that assessed ICD plus OMT versus OMT alone (after exclusion of trials that involved patients with CRT defibrillator), we found a statistically significant 24% reduction in all-cause mortality with ICD (hazard ratio, 0.76; 95% CI, 0.62–0.94). When we compared the 2 trials (COMPANION [Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure] and DANISH-CRT subgroup) with ICD plus CRT plus OMT versus CRT plus OMT alone, we found a trend toward benefit in terms of all-cause mortality in the ICD group, although it did not meet statistical significance (hazard ratio, 0.70; 95% CI, 0.39–1.26) (Figure).Download figureDownload PowerPointFigure. Forest plot of all-cause mortality among patients with nonischemic cardiomyopathy randomly assigned to ICD and CRT-D versus optimal medical therapy for primary prevention of sudden cardiac death. Black marker represents hazard ratio estimate for the study. The gray box around the marker corresponds to the weight of study in the random-effects model. The diamond-shaped box is the summary estimate from the random-effects model. The horizontal black lines denote 95% confidence intervals of hazard ratio of each study. The black vertical line is the line of no effect difference. AMIOVIRT indicates Amiodarone versus Implantable Cardioverter-Defibrillator Randomized Trial; CAT, cardiomyopathy trial; CI, confidence interval; COMPANION, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure; CRT, cardiac resynchronization therapy; CRT-D, cardiac resynchronization therapy defibrillator; DANISH, Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure; DEFINITE, Defibrillator in Nonischemic Cardiomyopathy Treatment Evaluation; HR, hazard ratio; ICD, implantable cardioverter-defibrillator; and SCD-HeFT, Sudden Cardiac Death in Heart Failure Trial.Newly diagnosed NICM is a heterogeneous group of patients with heart failure, and prior studies demonstrate that, despite OMT, a subset of these patients remains at risk of sudden cardiac death.5 Our updated meta-analysis combining all available RCTs, including the recently published DANISH trial, demonstrates that ICDs reduce all-cause mortality by 23% in patients with NICM. This incremental reduction of all-cause mortality with ICD is substantial and provides support to the existing American College of Cardiology/American Heart Association guidelines until we acquire additional data.3 In addition, despite the individual subgroup analysis of COMPANION and DANISH trials demonstrating no incremental benefit of ICD in patients with CRT, when we combined the 2 trials, we found that ICDs may still reduce all-cause mortality in patients who are also candidates of CRT therapy, although the results did not meet statistical significance. It may be plausible that, because of the high use of CRT in the DANISH trial (60% in each arm), ICD failed to demonstrate statistically significant effect on all-cause mortality in patients with NICM.Taken collectively, despite the neutral results of the recently published DANISH trial, our meta-analysis of all the published RCTs to date demonstrates significant clinical benefit on all-cause mortality in favor of ICD use for primary prevention in patients with NICM. Improvement in risk prediction models can help overcome the traditional reliance on ejection fraction for risk stratification of sudden cardiac death in NICM patients. Furthermore, adequately powered randomized studies are needed before recommending any change in existing guidelines, and clinical judgment should prevail while assessing risk of sudden cardiac death in NICM patients with reduced ejection fraction.Harsh Golwala, MD*Navkaranbir Singh Bajaj, MD, MPH*Garima Arora, MDPankaj Arora, MDSources of FundingThis work was supported in part by the Walter B. Frommeyer Junior Fellowship in Investigative Medicine that was awarded to Dr Arora.DisclosuresNone.Footnotes*Drs Golwala and Bajaj contributed equally.Circulation is available at http://circ.ahajournals.org.Correspondence to: Pankaj Arora, MD, Assistant Professor, Division of Cardiology, Department of Medicine, 1670 University Boulevard, Volker Hall B140, University of Alabama at Birmingham, Birmingham, AL 35294. E-mail [email protected]References1. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS.Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.J Am Coll Cardiol. 2004; 44:2166–2172. doi: 10.1016/j.jacc.2004.08.054.CrossrefMedlineGoogle Scholar2. Desai AS, Fang JC, Maisel WH, Baughman KL.Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.JAMA. 2004; 292:2874–2879. doi: 10.1001/jama.292.23.2874.CrossrefMedlineGoogle Scholar3. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.Circulation. 2013; 127:e283–e352. doi: 10.1161/CIR.0b013e318276ce9b.LinkGoogle Scholar4. Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S; DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure.N Engl J Med. 2016; 375:1221–1230. doi: 10.1056/NEJMoa1608029.CrossrefMedlineGoogle Scholar5. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK.Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.N Engl J Med. 2000; 342:1077–1084. doi: 10.1056/NEJM200004133421502.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Low Y and Dalia A (2022) Primary-Prevention ICDs: Is the Juice Worth the Squeeze?, Journal of Cardiothoracic and Vascular Anesthesia, 10.1053/j.jvca.2022.03.012, 36:8, (2253-2254), Online publication date: 1-Aug-2022. Kondaveeti G, Bhatia V, Lahm R, Harris M, Gaewsky J, Gayzik F, Greenhalgh J, Hamilton C, Stacey R and Weaver A (2022) Quantifying Cardiothoracic Variation with Posture and Respiration to Inform Cardiac Device Design, Cardiovascular Engineering and Technology, 10.1007/s13239-022-00631-5 Nies R, Frerker C, Adam M, Kuhn E, Mauri V, Nettersheim F, Braumann S, Wahlers T, Baldus S and Schmidt T (2021) Is there a benefit of ICD treatment in patients with persistent severely reduced systolic left ventricular function after TAVI?, Clinical Research in Cardiology, 10.1007/s00392-021-01826-x, 111:5, (492-501), Online publication date: 1-May-2022. Ursaru A, Petris A, Costache I, Nicolae A, Crisan A and Tesloianu N (2022) Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know, Journal of Cardiovascular Development and Disease, 10.3390/jcdd9040120, 9:4, (120) Anagnostopoulos I, Kousta M, Kossyvakis C, Lakka E, Paraskevaidis N, Schizas N, Alexopoulos N, Deftereos S and Giannopoulos G (2021) The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-021-01027-6, 63:3, (523-530), Online publication date: 1-Apr-2022. Yafasova A, Butt J, Elming M, Nielsen J, Haarbo J, Videbæk L, Olesen L, Steffensen F, Bruun N, Eiskjær H, Brandes A, Thøgersen A, Egstrup K, Gustafsson F, Hassager C, Svendsen J, Høfsten D, Torp-Pedersen C, Pehrson S, Thune J and Køber L (2021) Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality), Circulation, 145:6, (427-436), Online publication date: 8-Feb-2022. Park S (2022) Device treatment of heart failure, Journal of the Korean Medical Association, 10.5124/jkma.2022.65.1.26, 65:1, (26-36), Online publication date: 10-Jan-2022. Ribera A, Giménez E, Oristrell G, Osorio D, Marsal J, García-Pérez L, Ballesteros M, Ródenas E, Belahnech Y, Escalona R, Rivas N, Roca-Luque I, Ferreira-González I and Espallargues M (2022) Coste-efectividad del desfibrilador automático implantable para la prevención primaria de la muerte súbita cardiaca, Revista Española de Cardiología, 10.1016/j.recesp.2021.02.015, 75:1, (12-21), Online publication date: 1-Jan-2022. Ribera A, Giménez E, Oristrell G, Osorio D, Marsal J, García-Pérez L, Ballesteros M, Ródenas E, Belahnech Y, Escalona R, Rivas N, Roca-Luque I, Ferreira-González I and Espallargues M (2022) Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death, Revista Española de Cardiología (English Edition), 10.1016/j.rec.2021.05.004, 75:1, (12-21), Online publication date: 1-Jan-2022. Narins C, Aktas M, Chen A, McNitt S, Ling F, Younis A, Zareba W, Daubert J, Huang D, Rosero S, Kutyifa V and Goldenberg I (2022) Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy, JACC: Clinical Electrophysiology, 10.1016/j.jacep.2021.06.020, 8:1, (1-11), Online publication date: 1-Jan-2022. Kaur N, Pruthvi C and Rohit M (2021) Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction?, The Egyptian Heart Journal, 10.1186/s43044-021-00152-x, 73:1, Online publication date: 1-Dec-2021. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, Usui A, Okishige K, Kusano K, Kumagai K, Goya M, Kobayashi Y, Shimizu A, Shimizu W, Shoda M, Sumitomo N, Seo Y, Takahashi A, Tada H, Naito S, Nakazato Y, Nishimura T, Nitta T, Niwano S, Hagiwara N, Murakawa Y, Yamane T, Aiba T, Inoue K, Iwasaki Y, Inden Y, Uno K, Ogano M, Kimura M, Sakamoto S, Sasaki S, Satomi K, Shiga T, Suzuki T, Sekiguchi Y, Soejima K, Takagi M, Chinushi M, Nishi N, Noda T, Hachiya H, Mitsuno M, Mitsuhashi T, Miyauchi Y, Miyazaki A, Morimoto T, Yamasaki H, Aizawa Y, Ohe T, Kimura T, Tanemoto K, Tsutsui H and Mitamura H (2021) JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias, Journal of Arrhythmia, 10.1002/joa3.12491, 37:4, (709-870), Online publication date: 1-Aug-2021. Infante A, Koo C, Yip A, Lim Y, Yeo W, Quek S, Lim T, Seow S, Chai P, Ong C, Teo L, Singh D and Kojodjojo P (2021) Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients, Singapore Medical Journal, 10.11622/smedj.2019166, (347-352), Online publication date: 1-Jul-2021. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, Usui A, Okishige K, Kusano K, Kumagai K, Goya M, Kobayashi Y, Shimizu A, Shimizu W, Shoda M, Sumitomo N, Seo Y, Takahashi A, Tada H, Naito S, Nakazato Y, Nishimura T, Nitta T, Niwano S, Hagiwara N, Murakawa Y, Yamane T, Aiba T, Inoue K, Iwasaki Y, Inden Y, Uno K, Ogano M, Kimura M, Sakamoto S, Sasaki S, Satomi K, Shiga T, Suzuki T, Sekiguchi Y, Soejima K, Takagi M, Chinushi M, Nishi N, Noda T, Hachiya H, Mitsuno M, Mitsuhashi T, Miyauchi Y, Miyazaki A, Morimoto T, Yamasaki H, Aizawa Y, Ohe T, Kimura T, Tanemoto K, Tsutsui H and Mitamura H (2021) JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias, Circulation Journal, 10.1253/circj.CJ-20-0637, 85:7, (1104-1244), Online publication date: 25-Jun-2021. Doran B, Mei C, Varosy P, Kao D, Saxon L, Feldman A, DeMets D and Bristow M (2021) The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy, JACC: Heart Failure, 10.1016/j.jchf.2021.02.013, 9:6, (439-449), Online publication date: 1-Jun-2021. Atalaia A, Ben Yaou R, Wahbi K, De Sandre-Giovannoli A, Vigouroux C, Bonne G and Bonne G Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome', Journal of Neuromuscular Diseases, 10.3233/JND-200596, 8:3, (419-439) Kancharla K, Hayes D, Asirvatham S and Friedman P (2021) Indications for Pacemakers, Implantable Cardioverter‐Defibrillators, and Cardiac Resynchronization Therapy Cardiac Pacing, Defibrillation and Resynchronization, 10.1002/9781119264002.ch3, (86-124), Online publication date: 19-Apr-2021. Wong J, Roberts J and Healey J (2021) The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape, Canadian Journal of Cardiology, 10.1016/j.cjca.2021.01.024, 37:4, (644-654), Online publication date: 1-Apr-2021. Goldenberg I, Erath J, Russo A, Burch A, Assmus B, Bonderman D, McNitt S and Kutyifa V (2021) Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator, Heart Rhythm, 10.1016/j.hrthm.2020.11.025, 18:3, (404-410), Online publication date: 1-Mar-2021. Fernández Lozano I, Osca Asensi J and Alzueta Rodríguez J (2020) Registro Español de Desfibrilador Automático Implantable. XVI Informe Oficial de la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología (2019), Revista Española de Cardiología, 10.1016/j.recesp.2020.07.032, 73:12, (1026-1037), Online publication date: 1-Dec-2020. Fernández Lozano I, Osca Asensi J and Alzueta Rodríguez J (2020) Spanish Implantable Cardioverter-defibrillator Registry. 16th Official Report of the Heart Rhythm Association of the Spanish Society of Cardiology (2019), Revista Española de Cardiología (English Edition), 10.1016/j.rec.2020.07.015, 73:12, (1026-1037), Online publication date: 1-Dec-2020. Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J, Miura T, Mitsuhashi T, Kario K, Kondo Y, Ieda M, Hagiwara N, Murohara T, Takahashi K, Tomita H, Takeishi Y, Anzai T, Shimizu W, Watanabe M, Morino Y, Kato T, Tada H, Nakagawa Y, Yano M, Maemura K, Kimura T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Aizawa Y, Shimizu I, Izumi D, Ozaki K and Minamino T (2020) Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design, Diabetes Therapy, 10.1007/s13300-020-00924-9, 11:11, (2739-2755), Online publication date: 1-Nov-2020. Higgins A, Bjerre J, Parzynski C, Minges K, Ahmad T, Desai N, Enriquez A, Spatz E, Friedman D, Curtis J, Hlatky M and Freeman J (2020) Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation, The American Journal of Cardiology, 10.1016/j.amjcard.2020.07.035, 133, (116-125), Online publication date: 1-Oct-2020. Stecker E, Nazer B and Dewland T (2020) Primary Prevention ICDs in Nonischemic Cardiomyopathy, Journal of the American College of Cardiology, 10.1016/j.jacc.2020.06.008, 76:4, (416-418), Online publication date: 1-Jul-2020. Middour T, Rosenthal T, Abi‐Samra F, Bernard M, Khatib S, Polin G, Rogers P, Bober R and Morin D (2020) Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy, Journal of Cardiovascular Electrophysiology, 10.1111/jce.14395, 31:5, (1137-1146), Online publication date: 1-May-2020. Bennett R, Campbell T and Kumar S (2020) Catheter and Device Management of Inherited Cardiac Conditions, Heart, Lung and Circulation, 10.1016/j.hlc.2019.12.009, 29:4, (594-606), Online publication date: 1-Apr-2020. Fernández Lozano I, Osca Asensi J and Alzueta Rodríguez J (2019) Registro Español de Desfibrilador Automático Implantable. XV Informe Oficial de la Sección de Electrofisiología y Arritmias de la Sociedad Española de Cardiología (2018), Revista Española de Cardiología, 10.1016/j.recesp.2019.07.029, 72:12, (1054-1064), Online publication date: 1-Dec-2019. Fernández Lozano I, Osca Asensi J and Alzueta Rodríguez J (2019) Spanish Implantable Cardioverter-defibrillator Registry. 15th Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2018), Revista Española de Cardiología (English Edition), 10.1016/j.rec.2019.10.002, 72:12, (1054-1064), Online publication date: 1-Dec-2019. Kachur S and Morin D (2019) Who Should Receive a Wearable Defibrillator Vest at Hospital Discharge?, Current Cardiology Reports, 10.1007/s11886-019-1215-8, 21:10, Online publication date: 1-Oct-2019. Khamis A, El Moheb M, Nicolas J, Iskandarani G, Refaat M and Akl E (2019) Several reasons explained the variation in the results of 22 meta-analyses addressing the same question, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2019.05.023, 113, (147-158), Online publication date: 1-Sep-2019. McNally E and Amaral A (2019) Predicting Arrhythmia Risk in Dilated Cardiomyopathy Using Genetic Mutation Status, Journal of the American College of Cardiology, 10.1016/j.jacc.2019.07.034, 74:11, (1491-1493), Online publication date: 1-Sep-2019. Smolis-Bąk E, Chwyczko T, Kowalik I, Borowiec A, Maciąg A, Szwed H and Dąbrowski R (2019) Exercise training program in patients with NYHA III class systolic heart failure - Parallel comparison to the effects of resynchronization therapy, Advances in Medical Sciences, 10.1016/j.advms.2018.12.006, 64:2, (241-245), Online publication date: 1-Sep-2019. Lau D, Kalman J and Sanders P (2019) Primary prevention implantable cardioverter defibrillators in non‐ischaemic cardiomyopathy: challenging the Australian heart failure guidelines, Medical Journal of Australia, 10.5694/mja2.50248, 211:4, (154), Online publication date: 1-Aug-2019. Beaser A, Cifu A and Nayak H (2019) Primary Prevention of Sudden Cardiac Death, JAMA, 10.1001/jama.2019.7662, 322:2, (161), Online publication date: 9-Jul-2019. Wang N, Mezu‐Chukwu U, Adelstein E, Althouse A, Sharbaugh M, Jain S, Shalaby A, Voigt A and Saba S (2019) Sex‐specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block‐associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy, Annals of Noninvasive Electrocardiology, 10.1111/anec.12641, 24:4, Online publication date: 1-Jul-2019. Schultheiss H, Fairweather D, Caforio A, Escher F, Hershberger R, Lipshultz S, Liu P, Matsumori A, Mazzanti A, McMurray J and Priori S (2019) Dilated cardiomyopathy, Nature Reviews Disease Primers, 10.1038/s41572-019-0084-1, 5:1 Kadakia R, Link M, Dominic P and Morin D (2019) Sudden cardiac death in nonischemic cardiomyopathy, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2019.05.002, 62:3, (235-241), Online publication date: 1-May-2019. Lee T, Qian M, Mu L, Di Tullio M, Graham S, Mann D, Nakanishi K, Teerlink J, Lip G, Freudenberger R, Sacco R, Mohr J, Labovitz A, Ponikowski P, Lok D, Estol C, Anker S, Pullicino P, Buchsbaum R, Levin B, Thompson J, Homma S and Ye S (2019) Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial, ESC Heart Failure, 10.1002/ehf2.12407, 6:2, (297-307), Online publication date: 1-Apr-2019. Wang N, Hussain A, Adelstein E, Althouse A, Sharbaugh M, Jain S, Shalaby A, Voigt A and Saba S (2018) Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy, Annals of Noninvasive Electrocardiology, 10.1111/anec.12603, 24:2, (e12603), Online publication date: 1-Mar-2019. Gutman S, Costello B, Papapostolou S, Voskoboinik A, Iles L, Ja J, Hare J, Ellims A, Kistler P, Marwick T and Taylor A (2018) Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar, European Heart Journal, 10.1093/eurheartj/ehy437, 40:6, (542-550), Online publication date: 7-Feb-2019. P. Schild D, I. Ricciardi S, G. Hellige J, Vogel R and Arenja N (2019) Current Pathophysiological and Genetic Aspects of Dilated Cardiomyopathy Visions of Cardiomyocyte - Fundamental Concepts of Heart Life and Disease [Working Title], 10.5772/intechopen.83567 Zaman S, Goldberger J and Kovoor P (2019) Sudden Death Risk-Stratification in 2018–2019: The Old and the New, Heart, Lung and Circulation, 10.1016/j.hlc.2018.08.027, 28:1, (57-64), Online publication date: 1-Jan-2019. El Moheb M, Nicolas J, Khamis A, Iskandarani G, Akl E and Refaat M (2018) Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012738.pub2, 2018:12 Fernández Lozano I, Osca Asensi J and Alzueta Rodríguez J (2018) Registro Español de Desfibrilador Automático Implantable. XIV Informe Oficial de la Sección de Electrofisiología y Arritmias de la Sociedad Española de Cardiología (2017), Revista Española de Cardiología, 10.1016/j.recesp.2018.07.027, 71:12, (1047-1058), Online publication date: 1-Dec-2018. Fernández Lozano I, Osca Asensi J and Alzueta Rodríguez J (2018) Spanish Implantable Cardioverter-defibrillator Registry. 14th Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2017), Revista Española de Cardiología (English Edition), 10.1016/j.rec.2018.08.024, 71:12, (1047-1058), Online publication date: 1-Dec-2018. Duncker D and Veltmann C (2018) Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure, Current Heart Failure Reports, 10.1007/s11897-018-0415-7, 15:6, (368-375), Online publication date: 1-Dec-2018. Mironov N and Golitsyn S (2018) Review of New American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Kardiologiia, 10.18087/cardio.2018.11.10201, 58:11, (94-100) Al-Khatib S, Stevenson W, Ackerman M, Bryant W, Callans D, Curtis A, Deal B, Dickfeld T, Field M, Fonarow G, Gillis A, Granger C, Hammill S, Hlatky M, Joglar J, Kay G, Matlock D, Myerburg R and Page R (2018) 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Journal of the American College of Cardiology, 10.1016/j.jacc.2017.10.054, 72:14, (e91-e220), Online publication date: 1-Oct-2018. Al-Khatib S, Stevenson W, Ackerman M, Bryant W, Callans D, Curtis A, Deal B, Dickfeld T, Field M, Fonarow G, Gillis A, Granger C, Hammill S, Hlatky M, Joglar J, Kay G, Matlock D, Myerburg R and Page R (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Heart Rhythm, 10.1016/j.hrthm.2017.10.036, 15:10, (e73-e189), Online publication date: 1-Oct-2018. Patel N and Bajaj N (2017) Meta-analyses: How to critically appraise them?, Journal of Nuclear Cardiology, 10.1007/s12350-017-0898-8, 25:5, (1598-1600), Online publication date: 1-Oct-2018. Halliday B, Gulati A, Ali A, Newsome S, Lota A, Tayal U, Vassiliou V, Arzanauskaite M, Izgi C, Krishnathasan K, Singhal A, Chiew K, Gregson J, Frenneaux M, Cook S, Pennell D, Collins P, Cleland J and Prasad S (2018) Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy, European Journal of Heart Failure, 10.1002/ejhf.1216, 20:10, (1392-1400), Online publication date: 1-Oct-2018. Al-Khatib S, Stevenson W, Ackerman M, Bryant W, Callans D, Curtis A, Deal B, Dickfeld T, Field M, Fonarow G, Gillis A, Granger C, Hammill S, Hlatky M, Joglar J, Kay G, Matlock D, Myerburg R and Page R (2018) 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Circulation, 138:13, (e272-e391), Online publication date: 25-Sep-2018. Pathak R, Sanders P and Deo R (2018) Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy, European Heart Journal, 10.1093/eurheartj/ehy344, 39:31, (2859-2866), Online publication date: 14-Aug-2018. Boriani G, Ziacchi M, Nesti M, Battista A, Placentino F, Malavasi V, Diemberger I and Padeletti L (2018) Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years?, International Journal of Cardiology, 10.1016/j.ijcard.2018.01.039, 261, (119-129), Online publication date: 1-Jun-2018. Ganga H, Maan A and Kevin Heist E (2018) Should Primary Prevention ICDs Still Be Placed in Patients with Non-ischemic Cardiomyopathy? A Review of the Evidence, Current Cardiology Reports, 10.1007/s11886-018-0974-y, 20:5, Online publication date: 1-May-2018. Lund L, Køber L, Swedberg K and Ruschitzka F (2018) The year 2017 in cardiology: heart failure, Cardiologia Croatica, 10.15836/ccar2018.154, 13:3-4, (154-164) Jiménez-Candil J, Díaz Infante E, Guerra J and Pérez-Castellano N (2018) Selección de lo mejor del año 2017 en desfibriladores implantables, Revista Española de Cardiología, 10.1016/j.recesp.2017.10.039, 71:4, (304-305), Online publication date: 1-Apr-2018. Jiménez-Candil J, Díaz Infante E, Guerra J and Pérez-Castellano N (2018) Selection of the Best of 2017 in Implantable Defibrillators, Revista Española de Cardiología (English Edition), 10.1016/j.rec.2018.01.004, 71:4, (304-305), Online publication date: 1-Apr-2018. Lund L, Køber L, Swedberg K and Ruschitzka F (2018) The year in cardiology 2017: heart failure, European Heart Journal, 10.1093/eurheartj/ehx782, 39:10, (832-839), Online publication date: 7-Mar-2018. Ehdaie A, Cingolani E, Shehata M, Wang X, Curtis A and Chugh S (2018) Sex Differences in Cardiac Arrhythmias, Circulation: Arrhythmia and Electrophysiology, 11:3, Online publication date: 1-Mar-2018. Boriani G and Malavasi V (2017) Extending survival by reducing sudden death with implantable cardioverter-defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies, European Journal of Heart Failure, 10.1002/ejhf.1080, 20:3, (420-426), Online publication date: 1-Mar-2018. Gaita F, Castagno D and Anselmino M (2018) Use of implantable cardioverter defibrillator in nonischaemic cardiomyopathy, Journal of Cardiovascular Medicine, 10.2459/JCM.0000000000000580, 19, (e63-e67), Online publication date: 1-Feb-2018. Alba A, Foroutan F, Duero Posada J, Battioni L, Schofield T, Alhussein M, Agoritsas T, Spencer F and Guyatt G (2017) Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis, Heart, 10.1136/heartjnl-2017-311430, 104:3, (230-236), Online publication date: 1-Feb-2018. Wang N, Li J, Adelstein E, Althouse A, Sharbaugh M, Jain S, Mendenhall G, Shalaby A, Voigt A and Saba S (2018) New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study, Pacing and Clinical Electrophysiology, 10.1111/pace.13264, 41:2, (143-154), Online publication date: 1-Feb-2018. Katritsis D and Auricchio A (2018) Do We Need an Implantable Cardioverter-defibrillator for Primary Prevention in Cardiac Resynchronisation Therapy Patients?, Arrhythmia & Electrophysiology Review, 10.15420/aer.2018.7.3.EO1, 7:3, (157), . Lewis K, Carroll S, Birnie D, Stacey D and Matlock D (2018) Incorporating patients' preference diagnosis in implantable cardioverter defibrillator decision-making, Current Opinion in Cardiology, 10.1097/HCO.0000000000000464, 33:1, (42-49), Online publication date: 1-Jan-2018. Dukkipati S, Koruth J, Choudry S, Miller M, Whang W and Reddy V (2017) Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease, Journal of the American College of Cardiology, 10.1016/j.jacc.2017.10.030, 70:23, (2924-2941), Online publication date: 1-Dec-2017. Steinberg B, Mulpuru S, Fang J and Gersh B (2017) Sudden death mechanisms in nonischemic cardiomyopathies: Insights gleaned from clinical implantable cardioverter-defibrillator trials, Heart Rhythm, 10.1016/j.hrthm.2017.09.025, 14:12, (1839-1848), Online publication date: 1-Dec-2017. Morin D, Homoud M and Estes N (2017) Prediction and Prevention of Sudden Cardiac Death, Cardiac Electrophysiology Clinics, 10.1016/j.ccep.2017.07.012, 9:4, (631-638), Online publication date: 1-Dec-2017. Zipse M and Tzou W (2017) Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment, Journal of Cardiovascular Electrophysiology, 10.1111/jce.13284, 28:11, (1361-1366), Online publication date: 1-Nov-2017. Dilaveris P, Antoniou C and Gatzoulis K (2017) Arrhythmic risk stratification in non-ischemic dilated cardiomyopathy: Where do we stand after DANISH?, Trends in Cardiovascular Medicine, 10.1016/j.tcm.2017.06.003, 27:8, (542-555), Online publication date: 1-Nov-2017. Ezekowitz J, O'Meara E, McDonald M, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton P, Heckman G, Howlett J, Koshman S, Lepage S, McKelvie R, Moe G, Rajda M, Swiggum E, Virani S, Zieroth S, Al-Hesayen A, Cohen-Solal A, D'Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez A, Kouz S, LeBlanc M, Masoudi F, Ross H, Roussin A and Sussex B (2017) 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure, Canadian Journal of Cardiology, 10.1016/j.cjca.2017.08.022, 33:11, (1342-1433), Online publication date: 1-Nov-2017. Disertori M, Masè M, Rigoni M, Nollo G, Arbustini E and Ravelli F (2017) Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients, Frontiers in Physiology, 10.3389/fphys.2017.00873, 8 Madeira M, António N, Milner J, Ventura M, Cristóvão J, Costa M, Nascimento J, Elvas L, Gonçalves L and Mariano Pego G (2017) Who still remains at risk of arrhythmic death at time of implantable cardioverter-defibrillator generator replacement?, Pacing and Clinical Electrophysiology, 10.1111/pace.13163, 40:10, (1129-1138), Online publication date: 1-Oct-2017. Leyva F, Zegard A, Acquaye E, Gubran C, Taylor R, Foley P, Umar F, Patel K, Panting J, Marshall H and Qiu T (2017) Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy, Journal of the American College of Cardiology, 10.1016/j.jacc.2017.07.712, 70:10, (1216-1227), Online publication date: 1-Sep-2017. El Moheb M, Nicolas J, Iskandarani G, Akl E and Refaat M (2017) Implantable cardiac defibrillators for patients with non-ischaemic cardiomyopathy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012738 Golwala H, Bajaj N, Arora G and Arora P (2017) Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis", Circulation, 135:25, (e1200-e1202), Online publication date: 20-Jun-2017.Nery P, Lewis K and Birnie D (2017) Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis", Circulation, 135:25, (e1198-e1199), Online publication date: 20-Jun-2017.Barakat A, Saad M and Elgendy I (2017) Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis", Circulation, 135:25, (e1196-e1197), Online publication date: 20-Jun-2017. Barakat A, Saad M, Elgendy A, Mentias A, Abuzaid A, Mahmoud A and Elgendy I (2017) Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials, BMJ Open, 10.1136/bmjopen-2017-016352, 7:6, (e016352), Online publication date: 1-Jun-2017. Manolis A (2017) Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge, Expert Review of Cardiovascular Therapy, 10.1080/14779072.2017.1307735, 15:4, (315-325), Online publication date: 3-Apr-2017. January 10, 2017Vol 135, Issue 2 Advertisement Article InformationMetrics © 2016 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.116.026056PMID: 27993908 Manuscript receivedOctober 20, 2016Manuscript acceptedDecember 1, 2016Originally publishedDecember 19, 2016 Keywordsdefibrillators, implantablearrhythmias, cardiaccardiomyopathiesPDF download Advertisement SubjectsCatheter Ablation and Implantable Cardioverter-DefibrillatorSudden Cardiac Death
Referência(s)